Enhanced anti-glioma efficacy of doxorubicin with BRD4 PROTAC degrader using targeted nanoparticles.
Mater Today Bio
; 16: 100423, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-36157053
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Mater Today Bio
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: